Doubts cast over the Moderna vaccine trial results knock out one leg from under the market rally. Investors are trying to bake in a scenario where economies reopen and a vaccine is available in time to prevent a second wave. But there are still many unknowns.
— Read on www.fxstreet.com/analysis/modernas-vaccine-rise-and-fall-202005200844

Insider trading, Fauci’s NIAID, Bill Gates 20 to 1 vaccine profit plan, Charles Lieber‘s CRISPR gene-editing nanotech that favors albinism over melanin connections to Israel and Wuhan lab make Moderna look like Enron 9/11 all over again.